MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

DexCom Inc

Închisă

SectorSănătate

68.23 1.43

Rezumat

Modificarea prețului

24h

Curent

Minim

66.46

Maxim

68.49

Indicatori cheie

By Trading Economics

Venit

17M

152M

Vânzări

119M

1.1B

P/E

Medie Sector

47.409

63.778

EPS

0.45

Marjă de profit

13.624

Angajați

10,200

EBITDA

5M

242M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+53.59% upside

Dividende

By Dow Jones

Următoarele câștiguri

24 apr. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-7.9B

26B

Deschiderea anterioară

66.8

Închiderea anterioară

68.23

Sentimentul știrilor

By Acuity

15%

85%

26 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

DexCom Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

25 oct. 2024, 09:10 UTC

Câștiguri

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

26 iul. 2024, 20:16 UTC

Câștiguri

These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More -- Barrons.com

26 iul. 2024, 09:13 UTC

Top știri
Acțiuni populare

Stocks to Watch: DexCom, Coinbase, 3M, Hermès -- WSJ

26 iul. 2024, 08:56 UTC

Top știri

These Stocks Are Moving the Most Today: DexCom, Deckers, Coursera, Ford, Alphabet, Bristol Myers, 3M, and More -- Barrons.com

27 iun. 2024, 16:01 UTC

Câștiguri

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

Comparație

Modificare preț

DexCom Inc Așteptări

Obiectiv de preț

By TipRanks

53.59% sus

Prognoză pe 12 luni

Medie 103.4 USD  53.59%

Maxim 120 USD

Minim 82 USD

În baza a 18 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruDexCom Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

18 ratings

16

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

66.25 / 72.47Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

26 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.